JP Morgan Chase & Co’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.65M | Buy |
|
|||||
|
2025
Q2 | $2.46M | Sell |
|
|||||
|
2025
Q1 | $3.88M | Sell |
|
|||||
|
2024
Q4 | $11M | Sell |
|
|||||
|
2024
Q3 | $6.47M | Buy |
|
|||||
|
2024
Q2 | $2.12M | Buy |
|
|||||
|
2024
Q1 | $1.71M | Sell |
|
|||||
|
2023
Q4 | $2.21M | Sell |
|
|||||
|
2023
Q3 | $5.88M | Buy |
|
|||||
|
2023
Q2 | $5.52M | Sell |
|
|||||
|
2023
Q1 | $19.5M | Buy |
|
|||||
|
2022
Q4 | $22.8M | Buy |
|
|||||
|
2022
Q3 | $16.4M | Sell |
|
|||||
|
2022
Q2 | $15.4M | Sell |
|
|||||
|
2022
Q1 | $26.2M | Buy |
|
|||||
|
2021
Q4 | $18.1M | Buy |
|
|||||
|
2021
Q3 | $4.7M | Buy |
|
|||||
|
2021
Q2 | $6.99M | Sell |
|
|||||
|
2021
Q1 | $21.4M | Sell |
|
|||||
|
2020
Q4 | $31.9M | Buy |
|
|||||
|
2020
Q3 | $16.1M | Buy |
|
|||||
|
2020
Q2 | $6.74M | Sell |
|
|||||
|
2020
Q1 | $9.59M | Buy |
|
|||||
|
2019
Q4 | $6.87M | Buy |
|
|||||
|
2019
Q3 | $3.96M | Sell |
|
|||||
|
2019
Q2 | $7.49M | Buy |
|
|||||
|
2019
Q1 | $3.55M | Buy |
|
|||||
|
2018
Q4 | $1.55M | Buy |
|
|||||
|
2018
Q3 | $1.73M | Buy |
|
|||||
|
2018
Q2 | $683K | Sell |
|
|||||
|
2018
Q1 | $1.52M | Sell |
|
|||||
|
2017
Q4 | $2.43M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $194K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3K | Buy |
|